Infections and diabetic foot syndrome in field practice

Česká verzia

Authors: E. Záhumenský
Authors place of work: Diabetologická ordinace, Zlín
Published in the journal: Vnitř Lék 2006; 52(5): 411-416
Category: Diabetes and other subjects (infection, dermatovenerology and rheumatology) Hradec Králové 3 to 4 June 2005

Summary

In diabetic foot syndrome, the infection of diabetic ulceration is the critical parameter of classification, the most frequent reason of hospitalization and the main cause of amputations. Debridement and release of pressure are the critical steps of initial therapy of neuropathic ulceration showing no clinical signs of infection. Infection of neuroischemic foot is much more serious condition: in case of positive microbiological finding, antibiotic therapy is recommended even without any clinical signs of infection. Healing can be accelerated by ozone and Dermacyn therapy. Prevention of ulceration should be based on using appropriate shoes (with respect to risk factors) and PC plantography.

Key words:
diabetic foot - infection - ozone - Dermacyn - individually designed shoes - PC plantography

Zdroje

1. Mezinárodní pracovní skupina pro syndrom diabetické nohy: Syndrom diabetické nohy. Mezinárodní konsenzus. Praha: Galén 2000.

2. Meggit B. Surgical management of the diabetic foot. Br J Hosp Med 1976; 16: 227-232.

3. Mason JM, O´Kneefe C, Hutchinson A et al. A systematic review of foot ulcer in patients with type 2 diabetes mellitus II: Treatment. Diabetic Med 1999; 16: 889-909.

4. Wagner F. Classification and treatment program for diabetic, neuropatic and dysvascular foot problems. Instructional Course Lectures. Amer Acad Orthopaed Surgeons 1979; 28: 143-165.

5. Apelqvist J, Castenfors J, Larsson J et al. Wound classification is more important than site of ulceration in the outcome of diabetic foot ulcers. Diabet Med 1989; 6: 526-530.

6. Calhoun JH, Cantrell J, Cobos J et al. Treatment of diabetic foot infection: Wagner classification, therapy, and outcome. Foot Ankle1988; 9: 101-106.

7. Eneroth M, Larssson J, Apelqvist J. Deep foot infections in patients with diabetes and foot ulcer: an entity with different characteristics, treatments, and prognosis. J Diab Comp 1999; 13: 254-263.

8. Johnston CLW. Infection and diabetes mellitus. In: Pickup J, Williams G (Eds). Textbook of diabetes. Vol. 2. Oxford: Blackwell Science 1997: 70.1-70.14.

9. Jirkovská A. Aktuální problematika syndromu diabetické nohy. In: Perušičová J (Ed). Trendy soudobé diabetologie. Sv. 5. Praha: Galén 2001: 51-87.

10. Macfarlane RF, Jeffcoate WJ. Classification of foot ulcers: The S(AD) SAD system. Diabetic Foot 1999; 2: 123-131.

11. Lavery LA, Armstrong DG, Harkless LB. Classification of diabetes foot wounds. J Foot Ankle Surg 1996; 5: 528-531.

12. Edmonds ME, Foster AVM. Managing the diabetic foot. Oxford: Blackwell Science 2000.

13. Gough A, Clapperton M, Rolando N at al. Randomised placebo-controlled trial of granulocyte-colony stimulating factor in diabetic foot infection. Lancet 1997; 350: 855-859.

14. Apelqvist J. The diabetic foot: an economic view. Diabetes voice. Bull Intern Diabet Federation 2000; 45: 26-29.

15. Foster A, McColgan M, Edmonds M. Should oral antibiotics be given to clean foot ulcers with no cellulitis? Diabetetic Med 1998; 15(Suppl 2): S10.

16. Lipsky BA. A current approach to diabetic foot infections. Current Infectious Disease Reports 1999; 1: 253-260.

17. Longmaid III HE, Kruskal JB. Imaging infections in diabetic patients. In: Eliopoulos GM (Ed). Infectious disease clinics of North America. Philadelphia: WB Saunders 1995: 163-182.

18. Edmons ME. Zásady diagnostiky a léčby jednotlivých stadií syndromu diabetické nohy. In: Tošenovský P, Edmons ME et al. Moderní léčba syndromu diabetické nohy. Praha: Galén 2004: 51-53.

19. Záhumenský E. Profylaktická a terapeutická obuv. In: Tošenovský P, Edmons ME et al. Moderní léčba syndromu diabetické nohy. Praha: Galén 2004: 173-179.